%PDF-1.3
%ºß¬à
3 0 obj
<</Type /Page
/Parent 1 0 R
/Resources 2 0 R
/MediaBox [0 0 595.2799999999999727 841.8899999999999864]
/Contents 4 0 R
>>
endobj
4 0 obj
<<
/Length 8297
>>
stream
0.5670000000000001 w
0 G
0.24 0.47 0.85 RG
0.24 0.47 0.85 rg
79.3700787401574814 799.3703149606299121 m
79.3700787401574814 811.8945675552180319 69.2171659804148476 822.0474803149605805 56.6929133858267775 822.0474803149605805 c
44.1686607912387075 822.0474803149605805 34.0157480314960665 811.8945675552180319 34.0157480314960665 799.3703149606299121 c
34.0157480314960665 786.8460623660417923 44.1686607912387075 776.69314960629913 56.6929133858267775 776.69314960629913 c
69.2171659804148476 776.69314960629913 79.3700787401574814 786.8460623660417923 79.3700787401574814 799.3703149606299121 c
f
0. 0.71 0.47 RG
0. 0.71 0.47 rg
121.8897637795275699 799.3703149606299121 m
121.8897637795275699 811.8945675552180319 111.7368510197849218 822.0474803149605805 99.2125984251968589 822.0474803149605805 c
86.6883458306087959 822.0474803149605805 76.5354330708661479 811.8945675552180319 76.5354330708661479 799.3703149606299121 c
76.5354330708661479 786.8460623660417923 86.6883458306087959 776.69314960629913 99.2125984251968589 776.69314960629913 c
111.7368510197849218 776.69314960629913 121.8897637795275699 786.8460623660417923 121.8897637795275699 799.3703149606299121 c
f
1. 0.71 0. RG
1. 0.71 0. rg
100.6299212598425328 771.0238582677164914 m
100.6299212598425328 783.5481108623046111 90.4770085000998847 793.7010236220471597 77.9527559055118218 793.7010236220471597 c
65.4285033109237446 793.7010236220471597 55.2755905511811108 783.5481108623046111 55.2755905511811108 771.0238582677164914 c
55.2755905511811108 758.4996056731283716 65.4285033109237446 748.346692913385823 77.9527559055118218 748.346692913385823 c
90.4770085000998847 748.346692913385823 100.6299212598425328 758.4996056731283716 100.6299212598425328 771.0238582677164914 c
f
BT
/F2 18 Tf
20.6999999999999993 TL
0.157 g
141.7322834645669332 785.1970866141732586 Td
(Cancer Diagnosis Report) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.314 g
425.1968503937008563 785.1970866141732586 Td
(Date: 7/9/2025, 5:38:09 PM) Tj
ET
0.78 G
28.3464566929133888 762.5199212598424765 m
566.9291338582677326 762.5199212598424765 l
S
0.24 0.47 0.85 rg
28.3464566929133888 745.5120472440944468 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
1. g
39.6850393700787407 728.5041732283464171 Td
(Diagnosis) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 711.4962992125983874 Td
(Result: Malignant) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 691.6537795275589815 Td
(Confidence: 99.5%) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 671.8112598425196893 Td
(Risk Level: High Risk) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.24 0.47 0.85 rg
0.78 G
0. w
0.24 0.47 0.85 rg
39.6850393700787407 666.1419685039369369 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 651.9726771653542983 Td
(Recommendations) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 643.3033858267716596 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 629.1340944881889072 Td
(Immediate consultation with oncologist) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 620.4648031496062686 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 606.2955118110236299 Td
(Biopsy confirmation required) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 597.6262204724408775 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 583.4569291338582389 Td
(Consider imaging studies \(MRI, CT scan\)) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 574.7876377952756002 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 560.6183464566929615 Td
(Genetic counseling recommended) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0. 0.71 0.47 rg
28.3464566929133888 534.9411811023621794 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
1. g
39.6850393700787407 517.9333070866141497 Td
(Cancer Type) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 500.9254330708661769 Td
(Type: Lobular Carcinoma) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 481.082913385826771 Td
(Confidence: 67.0%) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 461.2403937007874219 Td
(Subtype\(s\): -) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 441.3978740157480161 Td
(Characteristics: Originates in milk-producing glands) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0. 0.71 0.47 rg
0.78 G
0. w
0. 0.71 0.47 rg
39.6850393700787407 424.3899999999999864 139.5183742190615135 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 410.2207086614173477 Td
(Subtype\(s\)) Tj
ET
0. 0.71 0.47 rg
0.78 G
0. w
0. 0.71 0.47 rg
179.2034135891402684 424.3899999999999864 370.7178462533793777 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
184.8727049277229355 410.2207086614173477 Td
(Characteristics) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 401.5514173228346522 139.5183742190615135 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 387.3821259842520135 Td
(-) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
179.2034135891402684 401.5514173228346522 370.7178462533793777 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
184.8727049277229355 387.3821259842520135 Td
(Originates in milk-producing glands) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
1. 0.71 0. rg
28.3464566929133888 361.7049606299212883 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 344.6970866141732586 Td
(Metastasis) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 327.6892125984252289 Td
(Status: Primary) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 307.846692913385823 Td
(Confidence: 96.0%) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 288.0041732283464171 Td
(Stage: Stage I-III) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 268.1616535433071249 Td
(Spread Risk: Low - Cancer localized to primary site) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 248.319133858267719 Td
(Locations: -) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
1. 0.71 0. rg
0.78 G
0. w
1. 0.71 0. rg
39.6850393700787407 231.3112598425196893 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
0.157 g
45.354330708661422 217.1419685039370506 Td
(Locations) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 208.4726771653543267 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 194.3033858267716596 Td
(-) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.47 0.24 0.85 rg
28.3464566929133888 168.6262204724409628 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
1. g
39.6850393700787407 151.6183464566929615 Td
(Tissue Change) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 134.6104724409449318 Td
(Type: Hyperplasia) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 114.7679527559056396 Td
(Severity: Mild) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 94.9254330708662337 Td
(Progression Risk: Low risk of progression) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.47 0.24 0.85 rg
0.78 G
0. w
0.47 0.24 0.85 rg
39.6850393700787407 77.917559055118204 155.8656441449750787 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 63.7482677165354517 Td
(Severity) Tj
ET
0.47 0.24 0.85 rg
0.78 G
0. w
0.47 0.24 0.85 rg
195.5506835150538336 77.917559055118204 354.3705763274658693 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
201.2199748536365007 63.7482677165354517 Td
(Progression Risk) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.78 G
0. w
endstream
endobj
5 0 obj
<</Type /Page
/Parent 1 0 R
/Resources 2 0 R
/MediaBox [0 0 595.2799999999999727 841.8899999999999864]
/Contents 6 0 R
>>
endobj
6 0 obj
<<
/Length 6992
>>
stream
0. w
0.78 G
0.47 0.24 0.85 rg
0.78 G
0. w
0.47 0.24 0.85 rg
39.6850393700787407 801.8899999999999864 155.8656441449750787 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 787.7207086614173477 Td
(Severity) Tj
ET
0.47 0.24 0.85 rg
0.78 G
0. w
0.47 0.24 0.85 rg
195.5506835150538336 801.8899999999999864 354.3705763274658693 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
201.2199748536365007 787.7207086614173477 Td
(Progression Risk) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 779.0514173228345953 155.8656441449750787 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 764.8821259842519567 Td
(Mild) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
195.5506835150538336 779.0514173228345953 354.3705763274658693 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
201.2199748536365007 764.8821259842519567 Td
(Low risk of progression) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.24 0.47 0.85 rg
28.3464566929133888 739.2049606299212883 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
1. g
39.6850393700787407 722.1970866141732586 Td
(Prognosis) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 705.1892125984252289 Td
(Outcome: Fair) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 685.346692913385823 Td
(Confidence: 74.0%) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 665.5041732283464171 Td
(5-year Survival Rate: 65.0%) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 645.6616535433070112 Td
(Monitoring: 3-month monitoring) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.24 0.47 0.85 rg
0.78 G
0. w
0.24 0.47 0.85 rg
39.6850393700787407 639.9923622047243725 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 625.8230708661417339 Td
(Risk Factors) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 617.1537795275589815 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 602.9844881889763428 Td
(Age over 50) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 594.3151968503937042 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 580.1459055118109518 Td
(Family history) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 571.4766141732283131 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 557.3073228346456744 Td
(Previous cancer diagnosis) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 548.6380314960630358 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 534.4687401574803971 Td
(Lifestyle factors) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0. 0.71 0.47 rg
28.3464566929133888 508.791574803149615 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
1. g
39.6850393700787407 491.7837007874015853 Td
(Therapy) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 474.7758267716535556 Td
(Primary: Surgery + Chemotherapy + Radiation) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 454.9333070866142066 Td
(Alternatives: Immunotherapy, Hormone Therapy, Clinical Trials) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 435.0907874015748007 Td
(Priority: Immediate) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 415.2482677165354517 Td
(Timeline: Immediate) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 395.4057480314961026 Td
(Success Rate: 85.0%) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0. 0.71 0.47 rg
0.78 G
0. w
0. 0.71 0.47 rg
39.6850393700787407 389.7364566929134071 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 375.5671653543307684 Td
(Side Effects) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 366.8978740157480729 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 352.7285826771653774 Td
(Fatigue) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 344.0592913385826819 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 329.8900000000000432 Td
(Nausea) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 321.2207086614173477 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 307.051417322834709 Td
(Hair loss) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 298.3821259842520135 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 284.212834645669318 Td
(Immune suppression) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0. 0.71 0.47 rg
0.78 G
0. w
0. 0.71 0.47 rg
39.6850393700787407 258.5356692913386496 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 244.3663779527560109 Td
(Recommendations) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 235.697086614173287 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 221.5277952755906199 Td
(Surgery + Chemotherapy + Radiation) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 212.8585039370079528 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 198.6892125984253425 Td
(Immunotherapy) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 190.0199212598426186 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 175.8506299212599515 Td
(Hormone Therapy) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 167.181338582677256 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 153.0120472440946742 Td
(Clinical Trials) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
1. 0.71 0. rg
28.3464566929133888 127.3348818897638779 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 110.3270078740158624 Td
(Genetic Analysis) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 93.3191338582678327 Td
(Mutations: BRCA1 mutation, TP53 mutation) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 73.4766141732284268 Td
(Risk Genes: BRCA1, TP53) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 53.6340944881891346 Td
(Hereditary Risk: High hereditary risk) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 33.7915748031497287 Td
(Risk Score: 1/10) Tj
ET
0.78 G
0.5670000000000001 w
endstream
endobj
7 0 obj
<</Type /Page
/Parent 1 0 R
/Resources 2 0 R
/MediaBox [0 0 595.2799999999999727 841.8899999999999864]
/Contents 8 0 R
>>
endobj
8 0 obj
<<
/Length 2596
>>
stream
0.5670000000000001 w
0.78 G
0.78 G
0.5670000000000001 w
1. 0.71 0. rg
0.78 G
0. w
1. 0.71 0. rg
39.6850393700787407 801.8899999999999864 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
0.157 g
45.354330708661422 787.7207086614173477 Td
(Family Screening) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 779.0514173228345953 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 764.8821259842519567 Td
(Immediate family screening recommended) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.47 0.24 0.85 rg
28.3464566929133888 739.2049606299212883 538.5826771653544256 -22.677165354330711 re
f
BT
/F2 12 Tf
13.7999999999999989 TL
1. g
39.6850393700787407 722.1970866141732586 Td
(Overall Risk & Next Steps) Tj
ET
BT
/F1 12 Tf
13.7999999999999989 TL
0.157 g
39.6850393700787407 705.1892125984252289 Td
(Overall Risk: High Risk) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
0.47 0.24 0.85 rg
0.78 G
0. w
0.47 0.24 0.85 rg
39.6850393700787407 699.5199212598424765 510.2362204724410049 -22.8385826771653555 re
f
BT
/F2 10 Tf
11.5 TL
1. g
45.354330708661422 685.3506299212598378 Td
(Next Steps) Tj
ET
0.78 G
0.5670000000000001 w
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 676.6813385826771992 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 662.5120472440944468 Td
(Immediate consultation with oncologist) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 653.8427559055118081 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 639.6734645669291695 Td
(Complete diagnostic workup) Tj
ET
0.96 g
0.78 G
0. w
0.96 g
39.6850393700787407 631.0041732283464171 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 616.8348818897637784 Td
(Treatment planning) Tj
ET
1. g
0.78 G
0. w
1. g
39.6850393700787407 608.1655905511811397 510.2362204724410049 -22.8385826771653555 re
f
BT
/F1 10 Tf
11.5 TL
0.314 g
45.354330708661422 593.9962992125983874 Td
(Support services consultation) Tj
ET
0.78 G
0.5670000000000001 w
0.78 G
0. w
0.78 G
0.5670000000000001 w
0.78 G
0.5670000000000001 w
BT
/F1 10 Tf
11.5 TL
0.471 g
5.3377952755909606 34.0159842519684616 Td
(This report is generated by the AI Cancer Diagnosis System. For professional medical advice, consult a licensed healthcare provider.) Tj
ET
BT
/F1 10 Tf
11.5 TL
0.471 g
214.987795275590571 17.0081102362203183 Td
(Contact: support@cancerdiagnosis.ai) Tj
ET
endstream
endobj
1 0 obj
<</Type /Pages
/Kids [3 0 R 5 0 R 7 0 R ]
/Count 3
>>
endobj
9 0 obj
<<
/Type /Font
/BaseFont /Helvetica
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
10 0 obj
<<
/Type /Font
/BaseFont /Helvetica-Bold
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
11 0 obj
<<
/Type /Font
/BaseFont /Helvetica-Oblique
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
12 0 obj
<<
/Type /Font
/BaseFont /Helvetica-BoldOblique
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
13 0 obj
<<
/Type /Font
/BaseFont /Courier
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
14 0 obj
<<
/Type /Font
/BaseFont /Courier-Bold
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
15 0 obj
<<
/Type /Font
/BaseFont /Courier-Oblique
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
16 0 obj
<<
/Type /Font
/BaseFont /Courier-BoldOblique
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
17 0 obj
<<
/Type /Font
/BaseFont /Times-Roman
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
18 0 obj
<<
/Type /Font
/BaseFont /Times-Bold
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
19 0 obj
<<
/Type /Font
/BaseFont /Times-Italic
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
20 0 obj
<<
/Type /Font
/BaseFont /Times-BoldItalic
/Subtype /Type1
/Encoding /WinAnsiEncoding
/FirstChar 32
/LastChar 255
>>
endobj
21 0 obj
<<
/Type /Font
/BaseFont /ZapfDingbats
/Subtype /Type1
/FirstChar 32
/LastChar 255
>>
endobj
22 0 obj
<<
/Type /Font
/BaseFont /Symbol
/Subtype /Type1
/FirstChar 32
/LastChar 255
>>
endobj
2 0 obj
<<
/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]
/Font <<
/F1 9 0 R
/F2 10 0 R
/F3 11 0 R
/F4 12 0 R
/F5 13 0 R
/F6 14 0 R
/F7 15 0 R
/F8 16 0 R
/F9 17 0 R
/F10 18 0 R
/F11 19 0 R
/F12 20 0 R
/F13 21 0 R
/F14 22 0 R
>>
/XObject <<
>>
>>
endobj
23 0 obj
<<
/Producer (jsPDF 3.0.1)
/CreationDate (D:20250709175500+05'30')
>>
endobj
24 0 obj
<<
/Type /Catalog
/Pages 1 0 R
/OpenAction [3 0 R /FitH null]
/PageLayout /OneColumn
>>
endobj
xref
0 25
0000000000 65535 f 
0000018467 00000 n 
0000020300 00000 n 
0000000015 00000 n 
0000000152 00000 n 
0000008501 00000 n 
0000008638 00000 n 
0000015682 00000 n 
0000015819 00000 n 
0000018536 00000 n 
0000018661 00000 n 
0000018792 00000 n 
0000018926 00000 n 
0000019064 00000 n 
0000019188 00000 n 
0000019317 00000 n 
0000019449 00000 n 
0000019585 00000 n 
0000019713 00000 n 
0000019840 00000 n 
0000019969 00000 n 
0000020102 00000 n 
0000020204 00000 n 
0000020552 00000 n 
0000020638 00000 n 
trailer
<<
/Size 25
/Root 24 0 R
/Info 23 0 R
/ID [ <6CCDBB66589C52BE5E40B2F2014B9BD7> <6CCDBB66589C52BE5E40B2F2014B9BD7> ]
>>
startxref
20742
%%EOF